TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $438,680 | -4.7% | 11,633 | -4.1% | 0.00% | – |
| Q2 2023 | $460,281 | +23.2% | 12,135 | -21.0% | 0.00% | – |
| Q1 2023 | $373,531 | -16.4% | 15,359 | -0.2% | 0.00% | – |
| Q4 2022 | $446,839 | +1.6% | 15,387 | +4.9% | 0.00% | – |
| Q3 2022 | $440,000 | -12.2% | 14,670 | +5.8% | 0.00% | -100.0% |
| Q2 2022 | $501,000 | -21.6% | 13,865 | -6.2% | 0.00% | 0.0% |
| Q1 2022 | $639,000 | -9.9% | 14,786 | +4.4% | 0.00% | – |
| Q4 2021 | $709,000 | -25.7% | 14,157 | -5.6% | 0.00% | -100.0% |
| Q3 2021 | $954,000 | -11.7% | 14,992 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $1,081,000 | -22.6% | 14,983 | -20.8% | 0.00% | 0.0% |
| Q1 2021 | $1,396,000 | +2.0% | 18,924 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $1,368,000 | +362.2% | 18,633 | +284.6% | 0.00% | – |
| Q1 2020 | $296,000 | +45.8% | 4,845 | +104.8% | 0.00% | – |
| Q2 2019 | $203,000 | -3.8% | 2,366 | +21.3% | 0.00% | – |
| Q1 2019 | $211,000 | -45.6% | 1,951 | -50.5% | 0.00% | – |
| Q3 2018 | $388,000 | -46.2% | 3,942 | -36.8% | 0.00% | -100.0% |
| Q2 2018 | $721,000 | -29.1% | 6,238 | -35.9% | 0.00% | 0.0% |
| Q4 2017 | $1,017,000 | -42.4% | 9,725 | -37.9% | 0.00% | -50.0% |
| Q3 2017 | $1,767,000 | +5.7% | 15,671 | +5.0% | 0.00% | 0.0% |
| Q2 2017 | $1,672,000 | -22.7% | 14,919 | -19.5% | 0.00% | 0.0% |
| Q1 2017 | $2,163,000 | +13.4% | 18,542 | +2.3% | 0.00% | 0.0% |
| Q4 2016 | $1,908,000 | -46.5% | 18,132 | -43.8% | 0.00% | -33.3% |
| Q3 2016 | $3,567,000 | +47.7% | 32,280 | +94.7% | 0.00% | 0.0% |
| Q2 2016 | $2,415,000 | +10.6% | 16,582 | +8.9% | 0.00% | 0.0% |
| Q1 2016 | $2,183,000 | -18.4% | 15,229 | -12.1% | 0.00% | 0.0% |
| Q4 2015 | $2,676,000 | +119.0% | 17,318 | +102.5% | 0.00% | +200.0% |
| Q3 2015 | $1,222,000 | -54.7% | 8,554 | -54.4% | 0.00% | -66.7% |
| Q2 2015 | $2,698,000 | -61.8% | 18,777 | -62.5% | 0.00% | -57.1% |
| Q1 2015 | $7,059,000 | +48.9% | 50,053 | +56.4% | 0.01% | +75.0% |
| Q4 2014 | $4,742,000 | -35.6% | 31,999 | -33.1% | 0.00% | -33.3% |
| Q3 2014 | $7,362,000 | +867.4% | 47,849 | +782.2% | 0.01% | +500.0% |
| Q2 2014 | $761,000 | +39.6% | 5,424 | +10.6% | 0.00% | 0.0% |
| Q1 2014 | $545,000 | -22.4% | 4,906 | -30.9% | 0.00% | 0.0% |
| Q4 2013 | $702,000 | +64.8% | 7,101 | +26.6% | 0.00% | – |
| Q3 2013 | $426,000 | – | 5,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |